College for Public Health and Social Justice Saint Louis University Saint Louis MO.
College of Medicine Baylor University Houston TX.
J Am Heart Assoc. 2023 Feb 7;12(3):e026590. doi: 10.1161/JAHA.122.026590. Epub 2023 Jan 25.
Background Prior research suggests an association between clinical outcomes in heart failure (HF) and social determinants of health (SDoH). Because providers should identify and address SDoH in care delivery, we evaluated how SDoH have been defined, measured, and evaluated in studies that examine HF outcomes. Methods and Results Following Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, databases were searched for observational or interventional studies published between 2009 and 2021 that assessed the influence of SDoH on outcomes. Selected articles were assessed for quality using a validated rating scheme. We identified 1373 unique articles for screening; 104 were selected for full-text review, and 59 met the inclusion criteria, including retrospective and prospective cohort, cross-sectional, and intervention studies. The majority examined readmissions and hospitalizations (k=33), mortality or survival (k=29), and success of medical devices and transplantation (k=8). SDoH examined most commonly included race, ethnicity, age, sex, socioeconomic status, and education or health literacy. Studies used a range of 1 to 9 SDoH as primary independent variables and 0 to 7 SDoH as controls. Multiple data sources were employed and frequently were electronic medical records linked with national surveys and disease registries. The effects of SDoH on HF outcomes were inconsistent because of the heterogeneity of data sources and SDoH constructs. Conclusions Our systematic review reveals shortcomings in measurement and deployment of SDoH variables in HF care. Validated measures need to be prospectively and intentionally collected to facilitate appropriate analysis, reporting, and replication of data across studies and inform the design of appropriate, evidence-based interventions that can ameliorate significant HF morbidity and societal costs.
先前的研究表明,心力衰竭(HF)的临床结果与健康的社会决定因素(SDoH)之间存在关联。由于提供者应在医疗服务中识别和解决 SDoH,因此我们评估了在研究 HF 结果时,SDoH 是如何被定义、衡量和评估的。
根据系统评价和荟萃分析的首选报告项目的指导方针,搜索了 2009 年至 2021 年期间发表的评估 SDoH 对结局影响的观察性或干预性研究的数据库。使用经过验证的评分方案评估选定文章的质量。我们对 1373 篇独特的文章进行了筛选;对 104 篇文章进行了全文审查,其中 59 篇符合纳入标准,包括回顾性和前瞻性队列、横断面和干预研究。大多数研究检查了再入院和住院(k=33)、死亡率或生存率(k=29)以及医疗设备和移植的成功率(k=8)。最常检查的 SDoH 包括种族、民族、年龄、性别、社会经济地位以及教育或健康素养。研究使用了 1 到 9 个 SDoH 作为主要独立变量和 0 到 7 个 SDoH 作为对照。采用了多种数据源,并且经常将电子病历与国家调查和疾病登记处相链接。由于数据来源和 SDoH 结构的异质性,SDoH 对 HF 结局的影响不一致。
我们的系统评价揭示了 HF 护理中 SDoH 变量测量和应用的不足。需要前瞻性和有针对性地收集经过验证的措施,以促进数据在研究之间的适当分析、报告和复制,并为设计适当的、基于证据的干预措施提供信息,这些干预措施可以减轻 HF 的严重发病率和社会成本。